Skip to main content
Top
Published in: European Journal of Epidemiology 7/2019

01-07-2019 | ESSAY

Expanding disease and undermining the ethos of medicine

Author: Bjørn Hofmann

Published in: European Journal of Epidemiology | Issue 7/2019

Login to get access

Abstract

The expansion of the concept of disease poses problems for epidemiology. Certainly, new diseases are discovered and more people are treated earlier and better. However, the historically unprecedented expansion is criticised for going too far. Overdiagnosis, overtreatment, and medicalization are some of the challenges heatedly debated in medicine, media, and in health policy making. How are we to analyse and handle the vast expansion of disease? Where can we draw the line between warranted and unwarranted expansion? To address this issue, which has wide implications for epidemiology, we need to understand how disease is expanded. This article identifies six ways that our conception of disease is expanded: by increased knowledge (epistemic), making more phenomena count as disease (ontological), doing more (pragmatic), defining more (conceptual), and by encompassing the bad (ethic) and the ugly (aesthetic). Expanding the subject matter of medicine extends its realm and power, but also its responsibility. It makes medicine accountable for ever more of human potential dis-eases. At the same time it blurs the borders and undermines the demarcation of medicine. Six specific advices can guide our action clarifying the subject matter of medicine in general and epidemiology in particular. To avoid unlimited responsibility and to keep medicine on par with its end, we need to direct the expansion of disease to what effectively identifies or reduces human suffering. Otherwise we will deplete medicine and undermine the greatest asset in health care: trust.
Footnotes
1
With expansion I mean increasing the extension of disease.
 
Literature
1.
go back to reference De Sauvages F. Nosologia methodica sistens morborum classes. Amsterdam: Fratrum de Tournes; 1768/1968. De Sauvages F. Nosologia methodica sistens morborum classes. Amsterdam: Fratrum de Tournes; 1768/1968.
2.
go back to reference World Health Organization. International statistical classification of diseases and related health problems. Geneva: World Health Organization; 2004. World Health Organization. International statistical classification of diseases and related health problems. Geneva: World Health Organization; 2004.
4.
go back to reference World Organization of Family Doctors (WONCA) International Classification Committee, ICPC-2. International classification of primary care. Oxford: Oxford University Press; 1998. World Organization of Family Doctors (WONCA) International Classification Committee, ICPC-2. International classification of primary care. Oxford: Oxford University Press; 1998.
5.
go back to reference World Health Organization. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001. World Health Organization. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001.
6.
go back to reference Kaplan RM, Ong M. Rationale and public health implications of changing CHD risk factor definitions. Annu Rev Public Health. 2007;28:321–44.CrossRefPubMed Kaplan RM, Ong M. Rationale and public health implications of changing CHD risk factor definitions. Annu Rev Public Health. 2007;28:321–44.CrossRefPubMed
10.
go back to reference Reid L. Is an indistinct picture “exactly what we need”? Objectivity, accuracy, and harm in imaging for cancer. J Eval Clin Pract. 2018;24(5):1055–64.CrossRefPubMed Reid L. Is an indistinct picture “exactly what we need”? Objectivity, accuracy, and harm in imaging for cancer. J Eval Clin Pract. 2018;24(5):1055–64.CrossRefPubMed
15.
go back to reference Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA, J Am Med Assoc. 1999;281(5):446–53.CrossRef Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA, J Am Med Assoc. 1999;281(5):446–53.CrossRef
16.
go back to reference Welch HG. Less medicine, more health: 7 assumptions that drive too much medical care. Boston: Beacon Press; 2015. Welch HG. Less medicine, more health: 7 assumptions that drive too much medical care. Boston: Beacon Press; 2015.
20.
go back to reference Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K. Renaming low risk conditions labelled as cancer. BMJ. 2018;362:k3322.CrossRefPubMed Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K. Renaming low risk conditions labelled as cancer. BMJ. 2018;362:k3322.CrossRefPubMed
22.
24.
go back to reference De Ville K. Medical malpractice in twentieth century United States. The interaction of technology, law and culture. Int J Technol Assess Health Care. 1998;14(2):197–211.CrossRefPubMed De Ville K. Medical malpractice in twentieth century United States. The interaction of technology, law and culture. Int J Technol Assess Health Care. 1998;14(2):197–211.CrossRefPubMed
27.
go back to reference Quebec Medical Association. Overdiagnosis: findings and action plan. Quebec: Quebec Medical Association; 2014. Quebec Medical Association. Overdiagnosis: findings and action plan. Quebec: Quebec Medical Association; 2014.
29.
go back to reference O’neill O. Autonomy and trust in bioethics. Cambridge: Cambridge University Press; 2002.CrossRef O’neill O. Autonomy and trust in bioethics. Cambridge: Cambridge University Press; 2002.CrossRef
33.
go back to reference Moynihan R. Scientists find new disease: motivational deficiency disorder. BMJ: Br Med J. 2006;332(7544):745.CrossRef Moynihan R. Scientists find new disease: motivational deficiency disorder. BMJ: Br Med J. 2006;332(7544):745.CrossRef
35.
go back to reference Bickerdike L, Booth A, Wilson PM, Farley K, Wright K. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open. 2017;7(4):e013384.CrossRefPubMedPubMedCentral Bickerdike L, Booth A, Wilson PM, Farley K, Wright K. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open. 2017;7(4):e013384.CrossRefPubMedPubMedCentral
36.
go back to reference Paprica PA, Culyer AJ, Elshaug AG, Peffer J, Sandoval GA. From talk to action: policy stakeholders, appropriateness, and selective disinvestment. Int J Technol Assess Health Care. 2015;31(4):236–40.CrossRefPubMedPubMedCentral Paprica PA, Culyer AJ, Elshaug AG, Peffer J, Sandoval GA. From talk to action: policy stakeholders, appropriateness, and selective disinvestment. Int J Technol Assess Health Care. 2015;31(4):236–40.CrossRefPubMedPubMedCentral
37.
go back to reference Hughes E, McKenny K. Decommissioning and disinvestment toolkit 2013–2014 Rayleigh. Essex: Castle Point and Rochford Clinical Commissioning Group; 2013. Hughes E, McKenny K. Decommissioning and disinvestment toolkit 2013–2014 Rayleigh. Essex: Castle Point and Rochford Clinical Commissioning Group; 2013.
Metadata
Title
Expanding disease and undermining the ethos of medicine
Author
Bjørn Hofmann
Publication date
01-07-2019
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 7/2019
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-019-00496-4

Other articles of this Issue 7/2019

European Journal of Epidemiology 7/2019 Go to the issue